Pharmaceutical formulations and methods for treating respiratory tract infections

Details for Australian Patent Application No. 2010229724 (hide)

Owner Pulmatrix, Inc.

Inventors Lipp, Michael M.; Clarke, Robert W.; Hava, David L.; Batycky, Richard; Hanrahan, John

Agent Davies Collison Cave

Pub. Number AU-A-2010229724

PCT Pub. Number WO2010/111644

Priority 61/163,763 26.03.09 US; 61/298,092 25.01.10 US; 61/163,767 26.03.09 US; 61/255,764 28.10.09 US; 61/163,772 26.03.09 US; 61/305,819 18.02.10 US

Filing date 26 March 2010

Wipo publication date 30 September 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/111644 Priority application(s): WO2010/111644

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229730-Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining

2010229721-Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis